The WAVE3/β-catenin oncogenic signaling regulates chemoresistance in triple negative breast cancer

Abstract

We identified a novel WAVE3/β-catenin oncogenic signaling axis that modulates chemoresistance of TNBC. This study suggests that a targeted therapeutic strategy against WAVE3 could be effective for the treatment of chemoresistant TNBC tumors.